Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shitong Huang

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapyWanli Zhang, Xupeiyao Shi, Shitong Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2025
Restoring tumor antigenicity activates the "bystander" T cell immune cycleYifan Yang, Qiumin Yu, Haoyu Zhang, et al.
Immunology|August 22, 2024
Altered epitopes enhance macrophage-mediated anti-tumour immunity to low-immunogenic tumour mutationsQiumin Yu, Tingran Zhang, Tiandi He, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapyWanli Zhang, Xupeiyao Shi, Shitong Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 2, 2025
Restoring tumor antigenicity activates the "bystander" T cell immune cycleYifan Yang, Qiumin Yu, Haoyu Zhang, et al.
Immunology|August 22, 2024
Altered epitopes enhance macrophage-mediated anti-tumour immunity to low-immunogenic tumour mutationsQiumin Yu, Tingran Zhang, Tiandi He, et al.
Pageof 3